Press Releases

October 22, 2012 Lupin Receives FDA Approval for its New Drug Application for Antara® Capsules

October 18, 2012 Lupin receives FDA approval for its Oral Contraceptive Kurvelo® Tablets; The Generic of Nordette® Tablets

October 17, 2012 Lupin receives FDA approval for Generic Avapro® Tablets

September 27, 2012 Lupin receives FDA approval for its Oral Contraceptive VyfemlaTM Tablets Generic of Ovcon® 35 Tablets

September 13, 2012 Lupin receives FDA approval for Generic Lexapro® Tablets e® Tablets

July 24, 2012 Record Sales & Profits Net Sales up 44%, PBT up 67%, PAT up 33% Quarter I Results, FY 2012-13

July 6, 2012 Ernst & Young announces Lupin Pharmaceuticals Inc., CEO Vinita Gupta as Entrepreneur of the Year, Maryland – 060712

June 5, 2012 Lupin receives FDA approval for SUPRAX® (Cefixime) Capsules, 400 mg NDA Approval to add to growing SUPRAX® Franchise ®

May 15, 2012 Lupin Launches Generic Combivir® Tablets